DT&CRO Co (XKRX:383930) Cash-to-Debt : N/A (As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is DT&CRO Co Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. DT&CRO Co's cash to debt ratio for the quarter that ended in Mar. 2024 was N/A.

The historical rank and industry rank for DT&CRO Co's Cash-to-Debt or its related term are showing as below:

During the past 4 years, DT&CRO Co's highest Cash to Debt Ratio was 4.20. The lowest was 0.00. And the median was 1.03.

XKRX:383930's Cash-to-Debt is not ranked ^*
in the Biotechnology industry.
Industry Median: 6.89
* Ranked among companies with meaningful Cash-to-Debt only.

DT&CRO Co Cash-to-Debt Historical Data

The historical data trend for DT&CRO Co's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

DT&CRO Co Cash-to-Debt Chart

DT&CRO Co Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Cash-to-Debt

1.23

1.46

4.20

0.35

DT&CRO Co Quarterly Data
	Jun21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Cash-to-Debt	Get a 7-Day Free Trial					1.81	0.71	0.41	0.35	N/A

Competitive Comparison of DT&CRO Co's Cash-to-Debt

For the Biotechnology subindustry, DT&CRO Co's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

DT&CRO Co's Cash-to-Debt Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, DT&CRO Co's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where DT&CRO Co's Cash-to-Debt falls into.

DT&CRO Co Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

DT&CRO Co's Cash to Debt Ratio for the fiscal year that ended in Dec. 2023 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	5532.71	/	(3577.288	+	12303.275)
	=	0.35

DT&CRO Co's Cash to Debt Ratio for the quarter that ended in Mar. 2024 is calculated as:

Do not have enough data to calculate Cash to Debt ratio.

DT&CRO Co (XKRX:383930) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.

DT&CRO Co Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of DT&CRO Co's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

DT&CRO Co (XKRX:383930) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » DT&CRO Co Ltd (XKRX:383930) » Definitions » Cash-to-Debt

Comparable Companies

Traded in Other Exchanges

N/A

Address

28, Baengnyeong-ro 20beon-gil, 2nd, 3rd, 4th floor, Na-dong, Cheoin-gu, Gyeonggi-do (Yubang-dong), Yongin-si, KOR, 17042

Website

http://www.dtncro.com

DT&CRO Co Ltd conducts a series of consigned research, from non-clinical GLP toxicity, PK, and efficacy tests required for licensing of pharmaceuticals, chemicals, health functional foods, cosmetics and medical devices, to analysis, bioactivity, clinical trials, and licensing consulting. provided as a service.

DT&CRO Co (XKRX:383930) Headlines

No Headlines